期刊文献+

后程加速超分割放疗联合消癌平治疗中晚期食管癌82例疗效观察 被引量:7

Observations of late course accelerated hyperfractionation radiotherapy and plus chinese medicine for advanced esophageal carcinoma
暂未订购
导出
摘要 目的:观察后程加速超分割放疗联合中药消癌平治疗中晚期食管癌的疗效及毒副反应。方法:将符合条件的164例食管癌患者随机分为后程加速超分割放疗组(简称单放组,82例)。和后程加速超分割放疗加消癌平治疗组(简称综合组,82例)。放疗方法两组相同,前3周为常规放疗(2Gy/次,1次/天,5天/周),后两周改为加速超分割放疗(1.5Gy/次,2次/天,间隔6小时以上,5天/周)。消癌平口服于放疗第一天开始(20ml/次,3次/天),直至放疗结束。结果:单放组和综合组的1、3、5年生存率分别为85.4%、43.9%、20.7%;90.2%、54.9%、36.6%,5年生存率有显著差异(P<0.05)。两组1、3、5年局部控制率分别为53.2%、29.3%、20.7%;69.5%、45.1%、40.2%,两组有显著差异(P<0.05)。两组患者的死亡原因均以肿瘤局部未控和复发为主。综合组因肿瘤局部未控和复发的死亡率59.6%明显低于单放组80.0%。两组比较有显著性差异(P<0.05),综合组的造血系统和消化系统反应均明显低于单放组。结论:后程加速超分割放射治疗加消癌平治疗提高了5年生存率,但毒性并未增加。 Objective:To evaluate the treatment results and side -reactions of esophageal carcinoma treated with late course accelerated hyperfraction radiotherapy plus Xiao Ai Ping chemo -therapy( LCAHR + C). Methods: One hundred and sixty four patients with carcinoma of the esophagus were randomized into two groups: LCAHR along group (82 patients) and LCAHR + Xiao Ai Ping group (82 patients). The same irradiation was given for both groups with conventional fractionation (2Gy daily,5 times a week) in the first 3 weeks and late course accelerated hyperfractionation ( 1.5Gy twice daily , a minimum interfraction interval of 6 hours ,5 days per week) in the late 2 weeks . The total dose was 60Gy/5 weeks. In LCAHR + Xiao Ai Ping group, Xiao Ai Ping was given (20ml/times ,3 times/day) , continuously until radiotherapy complete. Results: The 1 -,3 -,5 -year survival rates combined and LCAFR groups were 90.2% ,54.9% ,41.5% and 85.4% ,43.9% ,24.4%. There was statistical significance in the 5 - year survival rates . The 1 - ,3 - ,5 - year local control rates were 69.5% ,45.1% ,42.2% and 53.2% ,29.3% ,20.7% ( P 〈 0.05 ). The main death cause of two groups was local recurrence and uncontrolled tumor. The LCAFR + C group was lower (56.9%) than the LCAFR group (80.0%). There was statistical significance in the two groups (P 〈 0.05 ) . The hematopoiesis and gastrointestinal tract side - reactions in LCAFR group were more severe than those of LCAFR + C group. Conclusion: Late course accelerated hyperfractionation radiotherapy used simultaneously with Xiao Ai Ping can increase the overall survival rate, reduce acute side - effect.
出处 《现代肿瘤医学》 CAS 2008年第2期251-253,共3页 Journal of Modern Oncology
关键词 食管肿瘤 放射疗法 放射剂量分次 中药疗法 综合疗法 预后 esophageal neoplasms radiotherapy dose fractionation Chinese medicine therapy combined modality therapy prognosis
  • 相关文献

参考文献13

二级参考文献38

  • 1王志良,樊青霞,范魁生.消癌平临床疗效观察[J].河南医科大学学报,1994,29(1):79-80. 被引量:27
  • 2叶宏勋,赵莺.186例食管癌常规放疗和后程加速超分割放疗的疗效观察[J].现代肿瘤医学,2005,13(3):409-410. 被引量:7
  • 3袁秀英,范忠泽,黄秀英.消癌平注射液治疗14例晚期胃癌的临床观察[J].上海医药,1996(6):12-13. 被引量:27
  • 4萧树东,李德华,张德中,沈谋积,朱孝庭,栗原稔.应用ACNU与Me-CCNU联合化疗治疗进展期胃癌的随机研究[J].中华肿瘤杂志,1996,18(1):30-33. 被引量:3
  • 5乔学英 周道安.中晚期食管癌放射治疗配合卡铂的远期疗效[J].中华放射肿瘤学杂志,1997,6(2):118-119.
  • 6韩春 杨香然 等.食管癌后程加速放射治疗前瞻性随机研究[J].中华放射肿瘤学杂志,1999,8:192-192.
  • 7孙燕 徐昌文 见:徐昌文 吴善芳 孙燕.肺癌的疗效评定标准[A].见:徐昌文,吴善芳,孙燕.肺癌.第二版[C].上海:上海科学技术出版社,1993.220—222.
  • 8黄国俊 黄孝迈 黄偶麟 等 见:徐昌文 吴善芳 孙燕.肺癌的外科治疗[A].见:徐昌文,吴善芳,孙燕.肺癌.第二版[C].上海:上海科学出版社,1993.146.
  • 9[1]Tubiana M.Repopulation in human tumors,biological background for fractionation in radiotherapy [J].Acta Oncologica,1988,27:83.
  • 10[2]Peter LJ,Ang KK,Tbames HD.Experience with the conceomitant boost regimen at UT MD Anderson Cancer Center[J].The Second Shanghai International Conference On Radiation Oncology,1991,20:31.

共引文献190

同被引文献107

引证文献7

二级引证文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部